Feb. 13, 2012: [Materials Provided] Koichi Tanaka lectured at the Medical Treatment Innovation Symposium.

 Core researcher and General Manager Koichi Tanaka lectured on the topic, “Ensuring That MS Plays an Increasing Role in Medical Treatment Innovations – Contributing to Drug Discovery and Diagnostics with Next Generation Mass Spectrometry” at the Medical Treatment Innovation Symposium held in Tokyo on February 12. His lecture was attended by about 300 individuals, working primarily in the medical and pharmaceutical fields.
 He shared his expectations that achievements obtained from research and development in the FIRST Program will contribute to medical treatment innovation, and discussed future prospects for current Japanese research and development.